Hematologic Malignancies

Sagar Lonial MD Jeff P. Sharman MD Julie M. Vose MD MBA and Farhad Ravandi-Kashani MD review data from key hematologic malignancy presentations from the 2015 clinical oncology meeting in Chicago. Topics include multiple myeloma indolent non-Hodgkin’s Lymphoma chronic lymphocytic leukemia acute leukemia and myelodysplasias.

Share

Program Content

Activities

  • 19-28ζ CAR T-cells in R/R ALL
    19-28ζ CAR T-Cells Induce High CR Rate in Relapsed/Refractory Adult ALL
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Celgene

Genentech BioOncology

Incyte

Novartis Pharmaceuticals Corporation